Search Results - "Mazal, Juraj"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial

    Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial by Heigener, David F., Pereira, José Rodrigues, Felip, Enriqueta, Mazal, Juraj, Manzyuk, Lyudmila, Tan, Eng Huat, Merimsky, Ofer, Sarholz, Barbara, Esser, Regina, Gatzemeier, Ulrich

    Published in Targeted oncology (01-06-2015)
    “…The First-Line Erbitux in Lung Cancer (FLEX) trial showed that the addition of cetuximab to chemotherapy followed by weekly cetuximab maintenance significantly…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    P15. Crizotinib in metastatic ALK-positive lung cancer—results from clinical practice in Slovakia

    P15. Crizotinib in metastatic ALK-positive lung cancer—results from clinical practice in Slovakia by Berzinec, Peter, Kasan, Peter, Plank, Lukas, Andrasina, Igor, Godal, Robert, Mazal, Juraj, Cipkova, Andrea, Denkova, Lucia, Chowaniecova, Gabriela, Kuliskova, Iveta

    Published in Translational lung cancer research (01-10-2014)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: